BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25421300)

  • 1. Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario.
    Dixon M; Mahar AL; Helyer LK; Vasilevska-Ristovska J; Law C; Coburn NG
    Gastric Cancer; 2016 Jan; 19(1):150-9. PubMed ID: 25421300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
    Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
    Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
    Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH
    World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and survival in patients with gastric stump cancer.
    Huang H; Wang W; Chen Z; Jin JJ; Long ZW; Cai H; Liu XW; Zhou Y; Wang YN
    World J Gastroenterol; 2015 Feb; 21(6):1865-71. PubMed ID: 25684953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer.
    Schildberg C; Abbas M; Merkel S; Agaimy A; Dimmler A; Schlabrakowski A; Croner R; Leupolt J; Hohenberger W; Allgayer H
    J Surg Oncol; 2013 Nov; 108(6):409-13. PubMed ID: 24037722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
    Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
    Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.
    Ahmed S; Leis A; Fields A; Chandra-Kanthan S; Haider K; Alvi R; Reeder B; Pahwa P
    Cancer; 2014 Mar; 120(5):683-91. PubMed ID: 24222180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
    Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
    Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic analysis of tumor size in T4a stage gastric cancer].
    Liu HG; Liang H; Deng JY; Wang L; Liang YX; Jiao XG
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):230-4. PubMed ID: 23859324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.
    Li X; Liu Y; Cao B; Liu B; Bai T; Li X; Mei L; Che X
    Hepatogastroenterology; 2015; 62(138):507-11. PubMed ID: 25916091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
    Lordick F; Kang YK; Chung HC; Salman P; Oh SC; Bodoky G; Kurteva G; Volovat C; Moiseyenko VM; Gorbunova V; Park JO; Sawaki A; Celik I; Götte H; Melezínková H; Moehler M;
    Lancet Oncol; 2013 May; 14(6):490-9. PubMed ID: 23594786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in gastric cancer using log-normal censored regression model.
    Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
    Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study.
    Castro F; Shahal D; Tarajia M; Velásquez IM; Causadias MT; Herrera V; Gómez B; Cukier M; Motta J
    BMJ Open; 2017 Sep; 7(9):e017266. PubMed ID: 28947456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?
    Badgwell B; Cormier JN; Krishnan S; Yao J; Staerkel GA; Lupo PJ; Pisters PW; Feig B; Mansfield P
    Ann Surg Oncol; 2008 Oct; 15(10):2684-91. PubMed ID: 18649106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.